Investopedia: The Street Has Caught Covidien

For most of 2012 and 2013, Covidien (NYSE: COV ) was the not-so-little med-tech that could. In an environment were companies like Johnson ...

Seeking Alpha: Spectranetics Has Multiple Attractive Opportunities, But Will They Execute?

I've had a love/hate relationship with Spectranetics ( SPNC ) for more than 15 years now. I've always loved the potential of the ...

Investopedia: Stryker Seems Back On Track

It's hard to call the current state of the med-tech world healthy, but some companies are definitely starting to do better. Prominent a...

Investopedia: Where Do The Bears Go Next With St. Jude Medical?

In a sell-side world where Underperform/Sell ratings are pretty rare, is a bit of exception, as several analysts have either recommended th...

Investopedia: Abbott Adds Two Promising Products

Abbott Labs (NYSE: ABT ) has never been shy about using M&A to build its business, and it was generally assumed that more deals would ...

Seeking Alpha: AngioDynamics Stronger Than It Looks, But Not So Cheap

When AngioDynamics ( ANGO ) reported last night, it brought a challenging fiscal year to close for this small med-tech company. A combina...

Investopedia: Intuitive Surgical's Miss Looks Systemic And Company-Specific

It wasn't so long ago that Intuitive Surgical (Nasdaq: ISRG ) was one of the cleanest growth stories in med-tech, as hospitals seemin...

MassDevice: The Bulls May Have Run A Little Too Far With St. Jude Medical

Combine a bull market with increasing optimism that major med-tech markets are stabilizing, and it's not so hard to see why stocks like...

MassDevice: Can C.R. Bard Use A Windfall To Reignite Growth?

C.R. Bard (NYSE: BCR ) has a problem; specifically, a growth problem. While the company has #1 or #2 market share in markets that make up...

Seeking Alpha: Red-Hot Novadaq Shows There's Green In Being Green

There aren't a lot of great med-tech growth stories these days, and many of those are already quite expensive. Novadaq Technologies ( ...

Investopedia: Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain

Bargains are getting harder and harder to find in the med-tech sector these days, and with Medtronic (NYSE: MDT ) sporting a double-digit E...

Investopedia: It Gets A Little Harder From Here For Covidien

Covidien (NYSE: COV ) has been one of the strongest large-cap med-tech stories over the past year or so. At a time when companies like Johns...

Seeking Alpha: Maybe More Than Meets The Eye To Stryker's Numbers

With a majority of the major orthopedic and medical technology companies having reported now, it's pretty clear that key markets like ...

Investopedia: Is Controversy About Robot-Assisted Surgery Showing Up In Intuitive Surgical's Numbers?

There has always been controversy around Intuitive Surgical (Nasdaq: ISRG ) and its daVinci robotic surgical system. In recent months this ...

Investopedia: Pharma Is Doing All The Pulling For Johnson & Johnson

While other healthcare companies including Covidien (NYSE: COV ) and Abbott (NYSE: ABT ) have seen fit to split their drug and device busi...

Investopedia: AngioDynamics Still Struggling To Get Back On Track

Throughout what has proven to be a difficult time for small-cap medical device company AngioDynamics (Nasdaq: ANGO ), I've been optimi...

Seeking Alpha: Most Of The Action At Medical Action Will Come From Margins

When most med-tech companies trade at an EV-to-sales multiple of 2x to 4x, Medical Action Industries' ( MDCI ) 0.4x multiple is a prett...

Seeking Alpha: CareFusion On The Right Path

This recent melt-up in the market has left relatively few undervalued opportunities in the med-tech sector. While there are still some bar...